Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2004-02-03 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BARNEVILLE-CARTERET (50270), Manche
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SARL PHARMACIE DE LA COTE DES ISLES : revenue, balance sheet and financial ratios
SARL PHARMACIE DE LA COTE DES ISLES is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BARNEVILLE-CARTERET (50270),
this company of category PME
shows in 2022 a revenue of 4.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SARL PHARMACIE DE LA COTE DES ISLES (SIREN 452018948)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
4 134 328 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
201 597 €
177 204 €
155 238 €
243 057 €
226 292 €
313 700 €
361 161 €
275 865 €
237 665 €
266 423 €
EBITDA
N/C
N/C
N/C
371 301 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
5.9%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SARL PHARMACIE DE LA COTE DES ISLES generates positive net income of 202 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 266 k€ -> 202 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
201 597 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 12%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
11.866%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
76.785%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SARL PHARMACIE DE LA COTE DES ISLES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
262.513
199.139
141.793
98.573
77.703
57.821
40.668
26.361
17.762
11.866
Financial autonomy
25.569
30.472
38.093
46.974
53.508
58.86
64.7
70.262
72.117
76.785
Repayment capacity
None
None
None
None
None
None
4.223
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
6.341%
None%
None%
None%
Sector positioning
Debt ratio
11.872025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of SARL PHARMACIE DE LA COTE... (11.87) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
76.78%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent
In 2025, the financial autonomy of SARL PHARMACIE DE LA COTE... (76.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 96.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
96.062
Liquidity indicators evolution SARL PHARMACIE DE LA COTE DES ISLES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
106.908
120.664
113.883
152.122
259.477
184.291
150.744
103.712
92.936
96.062
Interest coverage
None
None
None
None
None
None
4.573
None
None
None
Sector positioning
Liquidity ratio
96.062025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch
In 2025, the liquidity ratio of SARL PHARMACIE DE LA COTE... (96.06) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SARL PHARMACIE DE LA COTE DES ISLES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
379 325 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
29
0
0
0
Customer payment term (days)
0
0
0
0
0
0
2
0
0
0
Supplier payment term (days)
0
0
0
0
0
0
34
0
0
0
Positioning of SARL PHARMACIE DE LA COTE DES ISLES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SARL PHARMACIE DE LA COTE DES ISLES is estimated at
3 202 392 €
(range 2 173 158€ - 5 024 994€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2173k€3202k€5024k€
3 202 392 €Range: 2 173 158€ - 5 024 994€
NAF 5 année 2025
Valuation method used
Net Income Multiple
201 597 €
×
15.9x
=3 202 392 €
Range: 2 173 159€ - 5 024 995€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SARL PHARMACIE DE LA COTE DES ISLES with other companies in the same sector:
Frequently asked questions about SARL PHARMACIE DE LA COTE DES ISLES
What is the revenue of SARL PHARMACIE DE LA COTE DES ISLES ?
The revenue of SARL PHARMACIE DE LA COTE DES ISLES in 2022 is 4.1 M€.
Is SARL PHARMACIE DE LA COTE DES ISLES profitable?
Yes, SARL PHARMACIE DE LA COTE DES ISLES generated a net profit of 202 k€ in 2025.
Where is the headquarters of SARL PHARMACIE DE LA COTE DES ISLES ?
The headquarters of SARL PHARMACIE DE LA COTE DES ISLES is located in BARNEVILLE-CARTERET (50270), in the department Manche.
Where to find the tax return of SARL PHARMACIE DE LA COTE DES ISLES ?
The tax return of SARL PHARMACIE DE LA COTE DES ISLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SARL PHARMACIE DE LA COTE DES ISLES operate?
SARL PHARMACIE DE LA COTE DES ISLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart